Daily News Podcast

FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome


 

The FDA approved cannabidiol oral solution for the treatment of two rare pediatric seizure disorders. Also today, it’s a good idea to urge expectant parents to have a prenatal pediatrician visit, the Trump administration proposes changes to HHS and the FDA (view the complete proposal here), and after being approved for adults, the Eversense continuous glucose monitoring system is safe, durable, and accurate in children.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

Study finds widespread use of medications with depression as side effect
MDedge Hematology and Oncology
New NIH consortium aims to coordinate pediatric research programs
MDedge Hematology and Oncology
Type 2 diabetes may promote Parkinson development
MDedge Hematology and Oncology
FDA database reveals many rheumatic and musculoskeletal adverse events on immunotherapies
MDedge Hematology and Oncology
Routine AAA screening for older men: more harm than good?
MDedge Hematology and Oncology
TNF inhibitor linked to one-third drop in total mortality
MDedge Hematology and Oncology
Impact of varicella vaccination on herpes zoster is not what was expected
MDedge Hematology and Oncology
Galectin-3: A post-MI prognostic biomarker for our times
MDedge Hematology and Oncology
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Hematology and Oncology
Patients going without as insulin prices skyrocket
MDedge Hematology and Oncology